Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

Roch Houot; Emmanuel Bachy; Guillaume Cartron; François-Xavier Gros; Franck Morschhauser; Lucie Oberic; Thomas Gastinne; Pierre Feugier; Rémy Duléry; Catherine Thieblemont; Magalie Joris; Fabrice Jardin; Sylvain Choquet; Olivier Casasnovas; Gabriel Brisou; Morgane Cheminant; Jacques-Olivier Bay; Francisco Llamas Gutierrez; Cédric Menard; Karin Tarte; Marie-Hélène Delfau; Cédric Portugues; Emmanuel Itti; Xavier Palard-Novello; Paul Blanc-Durand; Yassine Al Tabaa; Clément Bailly; Camille Laurent; François Lemonnier

doi:10.1038/s41591-023-02624-w

Journal Articles Nature Medicine Year : 2023

Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (18) , (19, 20) , (20, 19) , (21) , (22) , (21) , (23) , (21) , (24) , (25) , (26) , (21)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

Roch Houot

Function : Author
PersonId : 767105
ORCID : 0000-0003-1729-8213

Hôpital Sud [CHU Rennes]

Emmanuel Bachy

Function : Author
PersonId : 981999
ORCID : 0000-0003-2694-7510

Centre Hospitalier Lyon Sud [CHU - HCL]

Guillaume Cartron

Function : Author

CHU Montpellier = Montpellier University Hospital

François-Xavier Gros

Function : Author
PersonId : 1202468
ORCID : 0000-0001-8998-3039

Centre Hospitalier Universitaire de Bordeaux

Franck Morschhauser

Function : Author

Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365

Lucie Oberic

Function : Author

Service Hématologie - IUCT-Oncopole [CHU Toulouse]

Thomas Gastinne

Function : Author

Centre Hospitalier Universitaire de Nantes = Nantes University Hospital

Pierre Feugier

Function : Author

Nutrition-Génétique et Exposition aux Risques Environnementaux

Rémy Duléry

Function : Author

CHU Saint-Antoine [AP-HP]

Catherine Thieblemont

Function : Author
PersonId : 1212005
ORCID : 0000-0002-9941-2448

Hopital Saint-Louis [AP-HP]

Magalie Joris

Function : Author

CHU Amiens-Picardie

Fabrice Jardin

Function : Author
PersonId : 1284966
ORCID : 0000-0002-6804-7943

Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen

Sylvain Choquet

Function : Author
PersonId : 1202469
ORCID : 0000-0002-7791-0470

CHU Pitié-Salpêtrière [AP-HP]

Olivier Casasnovas

Function : Author

Service d'Hématologie Clinique (CHU de Dijon)

Gabriel Brisou

Function : Author

Institut Paoli-Calmettes

Morgane Cheminant

Function : Author

Hôpital Necker - Enfants Malades [AP-HP]

Jacques-Olivier Bay

Function : Author

CHU Clermont-Ferrand

Francisco Llamas Gutierrez

Function : Author

Department of Computer Science

Cédric Menard

Function : Author

Etablissement français du sang [Rennes]

Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]

Karin Tarte

Function : Author
PersonId : 757671
ORCID : 0000-0002-6809-917X
IdRef : 069185646

Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]

Etablissement français du sang [Rennes]

Marie-Hélène Delfau

Function : Author

Hôpital Henri Mondor

Cédric Portugues

Function : Author

The Lymphoma Academic Research Organisation [Lyon]

Emmanuel Itti

Function : Author

Hôpital Henri Mondor

Xavier Palard-Novello

Function : Author

CRLCC Eugène Marquis

Paul Blanc-Durand

Function : Author

Hôpital Henri Mondor

Yassine Al Tabaa

Function : Author

Scintidoc Nuclear Medicine Center [Montpellier]

Clément Bailly

Function : Author

Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes-Angers

Camille Laurent

Function : Author
PersonId : 948580
ORCID : 0000-0002-5375-7512

Institut Universitaire du Cancer de Toulouse - Oncopole

François Lemonnier

Function : Author

Hôpital Henri Mondor

Abstract

In the version of this article initially published, the title of the paper, now reading "Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial," appeared incorrectly as "Axicabtagene ciloleucel in large B cell lymphoma ineligible for autologous stem cell transplantation: the phase 2 ALYCANTE trial.

Domains

Human health and pathology

Fichier principal

41591_2023_Article_2624.pdf (502.54 Ko)

Origin	Publisher files allowed on an open archive
licence	Attribution

Dépôt NantesU M : Connect in order to contact the contributor

https://nantes-universite.hal.science/hal-04755672

Submitted on : Monday, October 28, 2024-9:22:25 AM

Last modification on : Saturday, December 7, 2024-10:48:03 AM

Dates and versions

hal-04755672 , version 1 (28-10-2024)

Licence

Attribution

Identifiers

HAL Id : hal-04755672 , version 1
DOI : 10.1038/s41591-023-02624-w
PUBMED : 37814064
PUBMEDCENTRAL : PMC10579050

Cite

Roch Houot, Emmanuel Bachy, Guillaume Cartron, François-Xavier Gros, Franck Morschhauser, et al.. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nature Medicine, 2023, 29 (10), pp.2665-2665. ⟨10.1038/s41591-023-02624-w⟩. ⟨hal-04755672⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

HCL CNRS UNIV-ANGERS CHLS FNCLCC PAOLI_CALMETTES MARQUIS BECQUEREL UPEC UNIV-LORRAINE UNIV-LILLE NGERE-UL SORBONNE-UNIVERSITE SU-MEDECINE BMS-UL CRCI2NA NANTES-UNIVERSITE UNIV-UT3 UT3-TOULOUSEINP UFR-MEDECINE-NANTES

0 View

0 Download

Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

Abstract

Domains

Dates and versions

Licence

Identifiers

Cite

Export

Collections

Altmetric

Share